2.17
price up icon5.34%   0.11
after-market After Hours: 2.20 0.03 +1.38%
loading
Lixte Biotechnology Holdings Inc stock is traded at $2.17, with a volume of 12,775. It is up +5.34% in the last 24 hours and up +35.62% over the past month. Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
See More
Previous Close:
$2.06
Open:
$2.04
24h Volume:
12,775
Relative Volume:
0.02
Market Cap:
$4.59M
Revenue:
-
Net Income/Loss:
$-4.69M
P/E Ratio:
-0.5865
EPS:
-3.7
Net Cash Flow:
$-3.81M
1W Performance:
+45.64%
1M Performance:
+35.62%
6M Performance:
-10.66%
1Y Performance:
-30.00%
1-Day Range:
Value
$2.04
$2.21
1-Week Range:
Value
$1.4501
$2.2499
52-Week Range:
Value
$1.31
$4.40

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Name
Name
Lixte Biotechnology Holdings Inc
Name
Phone
310 203 2902
Name
Address
248 ROUTE 25A, EAST SETAUKET
Name
Employee
4
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
LIXT's Discussions on Twitter

Compare LIXT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LIXT
Lixte Biotechnology Holdings Inc
2.17 4.59M 0 -4.69M -3.81M -3.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
464.56 119.70B 10.63B -479.80M -1.35B 13.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
754.87 82.75B 13.85B 4.65B 3.32B 35.06
Biotechnology icon
ARGX
Argen X Se Adr
614.59 36.73B 1.86B -40.29M -1.28B -4.16
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.74 32.53B 2.09B -332.26M 16.06M -4.14
Biotechnology icon
BNTX
Biontech Se Adr
120.72 28.50B 3.30B -501.07M 1.03B 11.54

Lixte Biotechnology Holdings Inc Stock (LIXT) Latest News

pulisher
Nov 23, 2024

Lixte Biotechnology Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024
pulisher
Nov 15, 2024

LIXTW (Lixte Biotechnology Holdings) Accounts Payable & Acc - GuruFocus.com

Nov 15, 2024
pulisher
Oct 29, 2024

LIXT stock touches 52-week low at $1.53 amid market challenges - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving PremarketVF (NYSE:VFC) - Benzinga

Oct 29, 2024
pulisher
Oct 28, 2024

LIXT stock touches 52-week low at $1.53 amid market challenges By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 23, 2024

Lixte Biotechnology granted extension to meet Nasdaq listing rules By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

Lixte Biotechnology granted extension to meet Nasdaq listing rules - Investing.com

Oct 23, 2024
pulisher
Oct 09, 2024

Lixte Biotechnology Holdings Inc WT (LIXTW-Q) QuotePress Release - The Globe and Mail

Oct 09, 2024
pulisher
Oct 01, 2024

Omeros (OMER) Shares Drop 5.04% Amid Financial Struggles - GuruFocus.com

Oct 01, 2024
pulisher
Oct 01, 2024

MRVI Stock Drops 5.11% Amid Financial Report Release - GuruFocus.com

Oct 01, 2024
pulisher
Sep 24, 2024

Lixte Biotechnology (NASDAQ:LIXT) Stock Price Down 2.1% - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy - GlobeNewswire

Sep 24, 2024
pulisher
Sep 23, 2024

Should investors be concerned about LYT’s high price-to-sales ratio? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Lilium (NASDAQ:LILM) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Liquidia Co. (NASDAQ:LQDA) Shares Bought by Rhumbline Advisers - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Pacer Advisors Inc. Has $16.07 Million Stock Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Lipella Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.41, Down -2.35 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Renaissance Technologies LLC Sells 2,000 Shares of LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Texas Permanent School Fund Corp Trims Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

First Eagle Investment Management LLC Increases Stake in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Huber Capital Management LLC Acquires 241,814 Shares of Lyft, Inc. (NASDAQ:LYFT) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Acadian Asset Management LLC Cuts Position in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Quest Partners LLC Invests $28,000 in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Investors who lost money with shares of Liquidia Corporation - openPR

Sep 19, 2024
pulisher
Sep 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - Kilgore News Herald

Sep 18, 2024
pulisher
Sep 11, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance

Sep 11, 2024
pulisher
Sep 10, 2024

Biotech Steals The Show Following Pre-Clinical Data Announcement - MSN

Sep 10, 2024
pulisher
Sep 05, 2024

Lixte Biotechnology Holdings Inc (LIXT) Stock: A Year of Decreases and Increases - The InvestChronicle

Sep 05, 2024
pulisher
Sep 04, 2024

LIXTLixte Biotechnology Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

LIXTE Receives U.S. Patent Issue Notification for Immune Oncology - GlobeNewswire

Sep 04, 2024
pulisher
Aug 31, 2024

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Short Interest Update - Defense World

Aug 31, 2024
pulisher
Aug 28, 2024

Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Aug 28, 2024
pulisher
Aug 27, 2024

Market Recap Check: Lixte Biotechnology Holdings Inc (LIXT)’s Positive Finish at 2.00, Up/Down 11.12 - The Dwinnex

Aug 27, 2024
pulisher
Aug 27, 2024

LIXT Stock: A Voyage Through Lixte Biotechnology Holdings Inc’s Finances - The InvestChronicle

Aug 27, 2024
pulisher
Aug 27, 2024

LIXT stock touches 52-week low at $1.55 amid market fluctuations - Investing.com

Aug 27, 2024
pulisher
Aug 26, 2024

First Patient Dosed with LIXTE’s LB-100 in New Clinical - GlobeNewswire

Aug 26, 2024
pulisher
Aug 26, 2024

First Patient Dosed with Lixte Biotechnology Holdings, Inc.?s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - Marketscreener.com

Aug 26, 2024
pulisher
Aug 26, 2024

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - StockTitan

Aug 26, 2024
pulisher
Aug 24, 2024

Lixte Biotechnology faces Nasdaq delisting over equity shortfall - Investing.com India

Aug 24, 2024
pulisher
Aug 20, 2024

LIXT (Lixte Biotechnology Holdings) PS Ratio : (As of Aug. 20, 2024) - GuruFocus.com

Aug 20, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) PS Ratio : (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) Inventory-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXTE Biotechnology Provides Update On Recent Activities and Developments - ForexTV.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) Purchase Of Investment : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) Owner Earnings per Shar - GuruFocus.com

Aug 19, 2024
pulisher
Aug 18, 2024

LIXT (Lixte Biotechnology Holdings) COGS-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

LIXT (Lixte Biotechnology Holdings) Debt-to-Equity : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 17, 2024

LIXT (Lixte Biotechnology Holdings) Effective Interest Rate on Debt % : 0.00% (As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

LIXT (Lixte Biotechnology Holdings) Effect of Exchange Rate Changes : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 16, 2024

LIXT (Lixte Biotechnology Holdings) Float Percentage Of Tot - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

LIXT (Lixte Biotechnology Holdings) Interest Coverage : 0 (At Loss) (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024

Lixte Biotechnology Holdings Inc Stock (LIXT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):